Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2023 09:45 ET | Source: Oculis SA

Oculis Completes Enrollment in Phase 3 OCS-01 OPTIMIZE Trial

Completed enrollment in Phase 3 OPTIMIZE trial brings OCS-01 one step further on the regulatory path to approval.If approved, OCS-01 has the potential to become the first once-daily, topical,...